Doxycycline hyclate and Requip drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Doxycycline hyclate (doxycycline hyclate) and Requip (ropinirole hydrochloride). Common drug interactions include neuropathy peripheral among females and chronic obstructive pulmonary disease among males.
The phase IV clinical study analyzes what interactions people have when they take Doxycycline hyclate and Requip. It is created by eHealthMe based on reports of 88 people who take the same drugs from the FDA, and is updated regularly.
What is Doxycycline hyclate?
Doxycycline hyclate has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 17,884 Doxycycline hyclate users. Check the latest studies of Doxycycline hyclate.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.
88 people who take Doxycycline hyclate and Requip together, and have interactions are studied.

What are the common drug interactions of Doxycycline Hyclate and Requip, by gender? *:
female:
- Neuropathy peripheral (surface nerve damage)
- Pneumonia
- Back pain
- Back disorder
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cough
- Fatigue (feeling of tiredness)
- Feeling jittery
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Hospitalisation
male:
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Death
- Confusional state
- Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
- Drug hypersensitivity
- Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
- Hallucination (an experience involving the perception of something not present)
- Hepatic enzyme increased
- Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
What are the common drug interactions of Doxycycline Hyclate and Requip, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Chronic kidney disease
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
- Renal disorder (kidney disease)
- Renal vein thrombosis (blood clot in renal vein)
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Weight decreased
50-59:
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Nausea (feeling of having an urge to vomit)
- Pain
- Vomiting
- Abdominal pain
- Abscess (pus)
- Actinomyces test positive
- Adverse event
- Anaphylactic reaction (serious allergic reaction)
- Appendicitis (inflammation of the appendix)
60+:
- Renal failure (kidney dysfunction)
- Chronic kidney disease
- Fall
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
- Neck pain
- Pain
- Injection site erythema (redness at injection site)
- Injection site oedema
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 35 people, 39.77%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 20 people, 22.73%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 15 people, 17.05%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 14.77%
- Pain: 11 people, 12.50%
- Infection: 9 people, 10.23%
- Stress And Anxiety: 7 people, 7.95%
- High Blood Pressure: 7 people, 7.95%
- High Blood Cholesterol: 7 people, 7.95%
- Drowsiness: 7 people, 7.95%
* Approximation only. Some reports may have incomplete information.
Do you take Doxycycline hyclate and Requip?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Doxycycline hyclate (17,884 reports)
- Requip (22,950 reports)
Browse all drug interactions of Doxycycline hyclate and Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Doxycycline hyclate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Doxycycline hyclate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Requip and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on doxycycline hyclate and ropinirole hydrochloride (the active ingredients of Doxycycline hyclate and Requip, respectively), and Doxycycline hyclate and Requip (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Coreg cause Ichthyosis? - now
- Could Baclofen cause Complex Partial Seizures? - 3 seconds ago
- Drug interactions of Ribasphere and Tramadol - 8 seconds ago
- Could Meprobamate cause High Blood Cholesterol? - 9 seconds ago
- Could Unasyn cause Swelling? - 11 seconds ago
- Could Onfi cause Nosebleed? - 13 seconds ago
- Drug interactions of Isoptin and Haloperidol - 14 seconds ago
- Drug interactions of Fish Oil and Carvedilol - 14 seconds ago
- Drug interactions of Plaquenil and Evista - 16 seconds ago
- Could Colecalciferol cause Dry Eyes? - 24 seconds ago